Canada · Delayed Price · Currency is CAD CareRx Statistics
Total Valuation
CareRx has a market cap or net worth of CAD 245.48 million. The enterprise value is 311.93 million.
| Market Cap | 245.48M |
| Enterprise Value | 311.93M |
Important Dates
The next estimated earnings date is Friday, March 6, 2026.
| Earnings Date | Mar 6, 2026 |
| Ex-Dividend Date | Dec 23, 2025 |
Share Statistics
CareRx has 62.78 million shares outstanding. The number of shares has increased by 6.72% in one year.
| Current Share Class | 62.78M |
| Shares Outstanding | 62.78M |
| Shares Change (YoY) | +6.72% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 1.05% |
| Owned by Institutions (%) | 37.57% |
| Float | 29.37M |
Valuation Ratios
The trailing PE ratio is 2,639.52 and the forward PE ratio is 23.27.
| PE Ratio | 2,639.52 |
| Forward PE | 23.27 |
| PS Ratio | 0.67 |
| PB Ratio | 2.81 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.82 |
| P/OCF Ratio | 8.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.77, with an EV/FCF ratio of 13.75.
| EV / Earnings | 3,354.08 |
| EV / Sales | 0.85 |
| EV / EBITDA | 12.77 |
| EV / EBIT | 35.34 |
| EV / FCF | 13.75 |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.94.
| Current Ratio | 1.13 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | 3.36 |
| Debt / FCF | 3.62 |
| Interest Coverage | 1.24 |
Financial Efficiency
Return on equity (ROE) is 0.11% and return on invested capital (ROIC) is 4.19%.
| Return on Equity (ROE) | 0.11% |
| Return on Assets (ROA) | 2.49% |
| Return on Invested Capital (ROIC) | 4.19% |
| Return on Capital Employed (ROCE) | 5.45% |
| Revenue Per Employee | 249,892 |
| Profits Per Employee | 63 |
| Employee Count | 1,508 |
| Asset Turnover | 1.65 |
| Inventory Turnover | 14.00 |
Taxes
In the past 12 months, CareRx has paid 32,000 in taxes.
| Income Tax | 32,000 |
| Effective Tax Rate | 25.60% |
Stock Price Statistics
The stock price has increased by +78.54% in the last 52 weeks. The beta is 0.78, so CareRx's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +78.54% |
| 50-Day Moving Average | 3.67 |
| 200-Day Moving Average | 3.19 |
| Relative Strength Index (RSI) | 56.58 |
| Average Volume (20 Days) | 102,740 |
Short Selling Information
The latest short interest is 865, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 865 |
| Short Previous Month | 1,548 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CareRx had revenue of CAD 366.34 million and earned 93,000 in profits. Earnings per share was 0.00.
| Revenue | 366.34M |
| Gross Profit | 109.20M |
| Operating Income | 8.83M |
| Pretax Income | 125,000 |
| Net Income | 93,000 |
| EBITDA | 20.48M |
| EBIT | 8.83M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 15.54 million in cash and 82.00 million in debt, with a net cash position of -66.45 million or -1.06 per share.
| Cash & Cash Equivalents | 15.54M |
| Total Debt | 82.00M |
| Net Cash | -66.45M |
| Net Cash Per Share | -1.06 |
| Equity (Book Value) | 87.27M |
| Book Value Per Share | 1.39 |
| Working Capital | 8.17M |
Cash Flow
In the last 12 months, operating cash flow was 29.62 million and capital expenditures -6.94 million, giving a free cash flow of 22.68 million.
| Operating Cash Flow | 29.62M |
| Capital Expenditures | -6.94M |
| Free Cash Flow | 22.68M |
| FCF Per Share | 0.36 |
Margins
Gross margin is 29.81%, with operating and profit margins of 2.41% and 0.03%.
| Gross Margin | 29.81% |
| Operating Margin | 2.41% |
| Pretax Margin | 0.03% |
| Profit Margin | 0.03% |
| EBITDA Margin | 5.59% |
| EBIT Margin | 2.41% |
| FCF Margin | 6.19% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 2.05%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 2.05% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -6.72% |
| Shareholder Yield | -4.66% |
| Earnings Yield | 0.04% |
| FCF Yield | 9.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 25, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 25, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
CareRx has an Altman Z-Score of 0.73 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.73 |
| Piotroski F-Score | 8 |